Literature DB >> 13730138

Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor.

J A OATES, A SJOERDSMA.   

Abstract

Entities:  

Keywords:  NERVOUS SYSTEM/pharmacology; OXIDASES/antagonists; TRYPTOPHAN/pharmacology

Mesh:

Substances:

Year:  1960        PMID: 13730138     DOI: 10.1212/wnl.10.12.1076

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  12 in total

Review 1.  Serotonin syndrome: a brief review.

Authors:  Philippe Birmes; Dominique Coppin; Laurent Schmitt; Dominique Lauque
Journal:  CMAJ       Date:  2003-05-27       Impact factor: 8.262

2.  α-adrenoceptor blocking drugs, pressor responses to noradrenaline, and the ankle jerk in man.

Authors:  C De B White; A Richens
Journal:  Br J Clin Pharmacol       Date:  1974-12       Impact factor: 4.335

Review 3.  Tricyclic antidepressant pharmacology and therapeutic drug interactions updated.

Authors:  P K Gillman
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

4.  Triphasic waves in serotonin syndrome.

Authors:  G L Dike
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

5.  The acute effects of oral (--)-tryptophan in human subjects.

Authors:  M H Greenwood; M H Lader; B D Kantameneni; G Curzon
Journal:  Br J Clin Pharmacol       Date:  1975-04       Impact factor: 4.335

Review 6.  Dextromethorphan, chlorphenamine and serotonin toxicity: case report and systematic literature review.

Authors:  Andrew A Monte; Ryan Chuang; Michael Bodmer
Journal:  Br J Clin Pharmacol       Date:  2010-12       Impact factor: 4.335

Review 7.  The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders.

Authors:  G MacQueen; L Born; M Steiner
Journal:  CNS Drug Rev       Date:  2001

8.  Is monoamine oxidase inhibitor induced myoclonus serotoninergically mediated?

Authors:  J J Askenasy; M D Yahr
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

Review 9.  The serotonin syndrome. Implicated drugs, pathophysiology and management.

Authors:  K A Sporer
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

10.  Efficacy, safety, and patient preference of monoamine oxidase B inhibitors in the treatment of Parkinson's disease.

Authors:  Bradley J Robottom
Journal:  Patient Prefer Adherence       Date:  2011-01-20       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.